SMS Pharmaceuticals Limited (NSE:SMSPHARMA)
India flag India · Delayed Price · Currency is INR
265.00
+2.47 (0.94%)
May 22, 2025, 3:29 PM IST

SMS Pharmaceuticals Statistics

Total Valuation

NSE:SMSPHARMA has a market cap or net worth of INR 23.27 billion. The enterprise value is 26.04 billion.

Market Cap 23.27B
Enterprise Value 26.04B

Important Dates

The next estimated earnings date is Tuesday, May 27, 2025.

Earnings Date May 27, 2025
Ex-Dividend Date Sep 23, 2024

Share Statistics

NSE:SMSPHARMA has 88.65 million shares outstanding. The number of shares has decreased by -0.31% in one year.

Current Share Class 88.65M
Shares Outstanding 88.65M
Shares Change (YoY) -0.31%
Shares Change (QoQ) +0.50%
Owned by Insiders (%) 46.96%
Owned by Institutions (%) 2.43%
Float 45.35M

Valuation Ratios

The trailing PE ratio is 33.58.

PE Ratio 33.58
Forward PE n/a
PS Ratio 2.98
PB Ratio 4.13
P/TBV Ratio 4.15
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 39.39
EV / Sales 3.34
EV / EBITDA 19.60
EV / EBIT 25.57
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.51
Debt / EBITDA 2.19
Debt / FCF n/a
Interest Coverage 5.43

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 7.72%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 6.52M
Profits Per Employee 552,206
Employee Count 1,197
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +26.18% in the last 52 weeks. The beta is 0.91, so NSE:SMSPHARMA's price volatility has been similar to the market average.

Beta (5Y) 0.91
52-Week Price Change +26.18%
50-Day Moving Average 224.60
200-Day Moving Average 262.03
Relative Strength Index (RSI) 64.48
Average Volume (20 Days) 177,860

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:SMSPHARMA had revenue of INR 7.80 billion and earned 660.99 million in profits. Earnings per share was 7.82.

Revenue 7.80B
Gross Profit 2.47B
Operating Income 990.95M
Pretax Income 882.82M
Net Income 660.99M
EBITDA 1.30B
EBIT 990.95M
Earnings Per Share (EPS) 7.82
Full Income Statement

Balance Sheet

The company has 90.66 million in cash and 2.85 billion in debt, giving a net cash position of -2.76 billion or -31.16 per share.

Cash & Cash Equivalents 90.66M
Total Debt 2.85B
Net Cash -2.76B
Net Cash Per Share -31.16
Equity (Book Value) 5.64B
Book Value Per Share 66.75
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 31.66%, with operating and profit margins of 12.70% and 8.47%.

Gross Margin 31.66%
Operating Margin 12.70%
Pretax Margin 11.31%
Profit Margin 8.47%
EBITDA Margin 16.60%
EBIT Margin 12.70%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.15%.

Dividend Per Share 0.40
Dividend Yield 0.15%
Dividend Growth (YoY) 33.33%
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield 0.31%
Shareholder Yield 0.46%
Earnings Yield 2.84%
FCF Yield n/a
Dividend Details

Stock Splits

The last stock split was on December 17, 2015. It was a forward split with a ratio of 10.

Last Split Date Dec 17, 2015
Split Type Forward
Split Ratio 10

Scores

Altman Z-Score n/a
Piotroski F-Score n/a